A Study on the effect of Dry Herbal Powder massage followed by Ayurvedic enema treatment using Varunadi and Ardhamatrika in people with High Cholestrol & Fat levels

Evaluating the Efficacy of Rookshana Purvaka Basti Karma with Varunadi Niruha and Ardhamatrika on Dyslipidemia - A randomized comparative clinical trial focused on Inflammatory and Lipid biomarkers - NIL

Status

Active, not recruiting

Phases

Phase 3

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2025/07/091171

Enrollment

160

Registered

2025-07-18

Start date

Unknown

Completion date

Unknown

Last updated

2025-07-21

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: E785- Hyperlipidemia, unspecified

Interventions

None listed

Eligibility

Inclusion criteria

Inclusion criteria: Patients willing for trail, is the first & foremost criteria. Subjects between the age group of 20 - 50 years irrespective of gender, religion, occupation and socioeconomic status. Abnormal serum lipid levels like Total cholesterol (200 mg/dl or more) , serum triglycerides (150 mg/dl or more), serum HDL (below 40 mg/dl) , serum LDL (130 mg/dl or more), and serum VLDL (30 mg/dl or more) . Patient having one or any of these. Having the clinical features of Dyslipidemia. Subjects fit for Basti Karma. Patients of Dyslipidemia with Controlled Hypertension, Controlled Hypothyroidism and Controlled diabetes mellitus.

Exclusion criteria

Exclusion criteria: Subjects below 20 years and above 50 years of age. Subjects unfit for Basti Karma. Patients with Angina, myocardial infraction, stroke, transient ischemic attack, heart and vascular surgery or major operations within 6 months prior to screening visit. Patient with a history or evidence of systemic disorders like Cardiac, hepatic, renal & neurological diseases. Diseases including Uncontrolled Diabetes mellitus, Liver Cirrhosis, Uncontrolled Hypothyroidism, Uncontrolled Hypertension & other malignancy. Pregnant and lactating women

Design outcomes

Primary

Measure	Time frame
a)lipid profile that includes serum total cholesterol, serum triglycerides, serum HDL, serum LDL & serum VLDL. b)Inflammatory Bio markers that includes CRP, Interleukin (IL)-6, Serum ferritin, ESR c)Lipid bio markers that includes Apolipoprotein B d)Other Objective parameters are body weight in Kg, BMI ( Body Mass index ), SGOT, SGPTTimepoint: Baseline, Day 7, Day 23	—

Secondary

Measure	Time frame
a)Fatigue b)Chest Discomfort c)Shortness of breath d)Palpitations e)Changes in Skin / Xanthelesma. Timepoint: Baseline, Day 7, Day 23	—

Countries

India

Contacts

Public ContactDr Sangeeta H Toshikhane

Parul Institute of Ayurveda, Parul University

drsangeetaj@gmail.com9964596479

Outcome results